Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A new avenue for a disease modifying treatment of Alzheimers?

Breland Smith, Federico Medda, Vijay Gokhale, Travis Dunckley, Christopher Hulme

Research output: Contribution to journal › Review article › peer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A new avenue for a disease modifying treatment of Alzheimers?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds